Many older Americans who begin taking GLP‑1 and related drugs for diabetes or weight loss stop the medications within months, often within a year, according to studies and patient accounts. Patients and researchers cite cost, side effects and coverage changes as common reasons for discontinuation.
The article recounts patients’